As of Mar 27
| +0.38 / +5.21%|
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +96.87% increase from the last price of 7.67.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.